{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T02:16:16Z","timestamp":1775960176549,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jss.2018.06.012","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T04:08:43Z","timestamp":1540440523000},"page":"383-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A Phase II Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Adrenocortical Carcinoma"],"prefix":"10.1016","volume":"232","author":[{"given":"Marybeth S.","family":"Hughes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winifred M.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Beresnev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Shutack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Taylor","family":"Ripley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2018.06.012_bib1","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2018.06.012_bib2","first-page":"635","article-title":"Current management options for recurrent adrenocortical carcinoma","volume":"6","author":"Glover","year":"2013","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jss.2018.06.012_bib3","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/cncr.23886","article-title":"Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors","volume":"113","author":"Bilimoria","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2018.06.012_bib4","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2013-3020","article-title":"Update in adrenocortical carcinoma","volume":"98","author":"Fassnacht","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jss.2018.06.012_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.critrevonc.2014.05.009","article-title":"Adrenocortical carcinoma: the management of metastatic disease","volume":"92","author":"Fay","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jss.2018.06.012_bib6","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.surg.2013.06.033","article-title":"Operative intervention for recurrent adrenocortical cancer","volume":"154","author":"Dy","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.jss.2018.06.012_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1210\/jc.2012-2559","article-title":"The role of surgery in the management of recurrent adrenocortical carcinoma","volume":"98","author":"Erdogan","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jss.2018.06.012_bib8","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1245\/s10434-012-2358-7","article-title":"Resection of adrenocortical carcinoma liver metastasis: is it justified?","volume":"19","author":"Gaujoux","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2018.06.012_bib9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/jso.23015","article-title":"Operative management for recurrent and metastatic adrenocortical carcinoma","volume":"105","author":"Datrice","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2018.06.012_bib10","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.athoracsur.2011.05.013","article-title":"Pulmonary resection for metastatic adrenocortical carcinoma: the National Cancer Institute experience","volume":"92","author":"Kemp","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jss.2018.06.012_bib11","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1245\/s10434-011-1564-z","article-title":"Liver resection and ablation for metastatic adrenocortical carcinoma","volume":"18","author":"Ripley","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2018.06.012_bib12","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.athoracsur.2011.07.088","article-title":"Metastatic adrenocortical carcinoma: results of 56 pulmonary metastasectomies in 24 patients","volume":"92","author":"Op den Winkel","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jss.2018.06.012_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12672-011-0088-0","article-title":"The Weiss Score and beyond \u2013 histopathology for adrenocortical carcinoma","volume":"2","author":"Papotti","year":"2011","journal-title":"Horm Cancer"},{"key":"10.1016\/j.jss.2018.06.012_bib14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10434-999-0719-7","article-title":"Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma","volume":"6","author":"Schulick","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2018.06.012_bib15","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1158\/1078-0432.CCR-16-1570","article-title":"Adrenocortical cancer: a molecularly complex disease where surgery matters","volume":"22","author":"Payabyab","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jss.2018.06.012_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jamcollsurg.2013.12.013","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients","volume":"218","author":"Levine","year":"2014","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jss.2018.06.012_bib17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","article-title":"Treatment factors associated with long-term survival following cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma","volume":"153","author":"Alexander","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.jss.2018.06.012_bib18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jamcollsurg.2013.12.013","article-title":"Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients","volume":"218","author":"Levine","year":"2014","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jss.2018.06.012_bib19","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1245\/s10434-013-3049-8","article-title":"Predicting postoperative morbidity following cytoreductive surgery with HIPEC with preoperative FACT-C and patient-rated performance status","volume":"20","author":"Ihemelandu","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2018.06.012_bib20","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/cncr.21708","article-title":"Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique","volume":"106","author":"Kusamara","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2018.06.012_bib21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","article-title":"Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal meothelioma","volume":"153","author":"Alexander","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.jss.2018.06.012_bib22","first-page":"1","article-title":"Outcome after resection of adrenocortical carcinoma liver metastases: a retrospective study","volume":"17","author":"Baur","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2018.06.012_bib23","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0039-6060(97)90229-4","article-title":"Role of reoperation in recurrence of adrenal cortical carcinoma: results of 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma","volume":"122","author":"Bellatone","year":"1997","journal-title":"Surgery"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480418303986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480418303986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:48:36Z","timestamp":1758379716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480418303986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":23,"alternative-id":["S0022480418303986"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2018.06.012","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Phase II Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Adrenocortical Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2018.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}